"Now that the Food and Drug Administration is using AI to "speed up" the drug approval process, it seems the sky's the limit on what wacko products are approved for commercial sale. The crypto company Tharimmune Inc, for example, was recently given "positive feedback" from the FDA on a drug called Nalmefene, clinically labeled TH104. According , the drug is being developed as a longer-lasting alternative to Nalaxone, an opioid-reversal agent which typical wears off in 20 to 90 minutes."
"Nalaxone is easily administered by non-medical personnel through the nose, and has become widely available either over the counter or through harm reduction programs. Nalmefene is different - and not without controversy. Per Filter, the drug isn't meant for reversing overdoses in people with substance abuse disorders, but in first responders and military members who might come in contact with them. It also increases the risk of fatal overdose in drug users."
The Food and Drug Administration is using AI to accelerate the drug approval process, enabling faster regulatory feedback. Tharimmune Inc., a company with a cryptocurrency focus, received positive FDA feedback for Nalmefene (TH104), a longer‑lasting opioid antagonist being developed as an alternative to nalaxone. Nalaxone is widely available and easily administered intranasally by non-medical personnel. Nalmefene is targeted for first responders and military personnel rather than people with substance use disorders and may increase fatal overdose risk among drug users. Fentanyl transdermal overdose is believed to be nearly impossible, and misconceptions about incidental contact harm interactions with vulnerable people.
Read at Futurism
Unable to calculate read time
Collection
[
|
...
]